DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
185 hedge funds and large institutions have $1.44B invested in DIPLOMAT PHARMACY, INC. in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 85 increasing their positions, 50 reducing their positions, and 17 closing their positions.
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
70% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 50
19% more call options, than puts
Call options by funds: $2.85M | Put options by funds: $2.41M
11% more funds holding
Funds holding: 166 → 185 (+19)
19% less capital invested
Capital invested by funds: $1.77B → $1.44B (-$329M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$34.5M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$16.5M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$14M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.56M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$7.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$42.2M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$16M |
| 3 |
O
OppenheimerFunds
New York
|
-$14.1M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.1M |
| 5 |
JP Morgan Chase
New York
|
-$9.09M |
DPLO Hedge Fund Activity: Q3 2016 in Review
185 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2016, worth a combined $1.44B — down 19% from $1.77B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new DPLO positions and 17 closed out — a net gain of 19 holders — while 85 added to existing stakes and 50 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $34.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $42.2M.
- 185 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2016, up from 166 in Q2 2016.
- Funds reported $1.44B of DIPLOMAT PHARMACY, INC. stock for Q3 2016, down 19% quarter-over-quarter.
- 36 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2016 and 17 closed out, a net change of +19 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2016 was Capital Research Global Investors, an estimated $34.5M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q3 2016 was T. Rowe Price Associates, an estimated $42.2M sold.
Based on aggregated 13F filings for Q3 2016.